- Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol
Miguel Olivas-Aguirre et al, 2021, Frontiers in Oncology CrossRef - Cancer Therapy Challenge: It Is Time to Look in the “St. Patrick’s Well” of the Nature
Gregorio Bonsignore et al, 2021, International Journal of Molecular Sciences CrossRef - Tamoxifen
Effat Davoudi-Monfared, 2024, Encyclopedia of Toxicology CrossRef - Tamoxifen Never Ceases to Amaze: New Findings on Non-Estrogen Receptor Molecular Targets and Mediated Effects
Tatiana Anatolievna Bogush et al, 2018, Cancer Investigation CrossRef - Construction of a cuproptosis-associated long non-coding RNA risk prediction model for pancreatic adenocarcinoma based on the TCGA database
Wenguang Cui et al, 2023, Medicine CrossRef - Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells
Shaw M. Akula et al, 2020, Advances in Biological Regulation CrossRef - Recent Advances in Herbal Medicines for Digestive System Malignancies
Jiyao Sheng et al, 2018, Frontiers in Pharmacology CrossRef - Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer
Takahito Kawano et al, 2022, Cancers CrossRef - Hepatotoxic mechanism of cantharidin: insights and strategies for therapeutic intervention
Dian Jin et al, 2023, Frontiers in Pharmacology CrossRef - Cantharidin alters the expression of genes associated with the NKG2D-associated immune response in TSGH-8301 human bladder carcinoma cells
Jehn-Hwa Kuo et al, 2017, Oncology Letters CrossRef - Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer: opportunities and challenges
Chaochao Yu et al, 2022, Journal of Zhejiang University-SCIENCE B CrossRef - Delineating the molecular mechanisms of tamoxifen’s oncolytic actions in estrogen receptor-negative cancers
Daniel P. Radin et al, 2016, European Journal of Pharmacology CrossRef - Measurement of Microcystin and Nodularin Activity in Human Urine by Immunocapture-Protein Phosphatase 2A Assay
Rebekah E. Wharton et al, 2019, Toxins CrossRef - Self-nanoemulsifying drug delivery system for pancreatic cancer
Neha Parveen et al, 2023, European Polymer Journal CrossRef - Tamoxifen induces toxicity, causes autophagy, and partially reverses dexamethasone resistance in Jurkat T cells
Liliana Torres-López et al, 2019, Journal of Leukocyte Biology CrossRef - Tamoxifen use and acute pancreatitis: A population-based cohort study
Fan-Gen Hsu et al, 2017, PLOS ONE CrossRef - Cantharidin and norcantharidin impair stemness of pancreatic cancer cells by repressing the β-catenin pathway and strengthen the cytotoxicity of gemcitabine and erlotinib
WEN-JIE WANG et al, 2015, International Journal of Oncology CrossRef - Norcantharidin: research advances in pharmaceutical activities and derivatives in recent years
Jianbo Zhou et al, 2020, Biomedicine & Pharmacotherapy CrossRef - Norcantharidin modulates miR-655-regulated SENP6 protein translation to suppresses invasion of glioblastoma cells
Zhenxing Zhang et al, 2016, Tumor Biology CrossRef - Norcantharidin induces autophagy-related prostate cancer cell death through Beclin-1 upregulation by miR-129-5p suppression
Wenjun Xiao et al, 2016, Tumor Biology CrossRef - Repurposing Tamoxifen for Tumor Microenvironment Priming and Enhanced Tumor‐Targeted Drug Delivery
Ilaria Biancacci et al, 2023, Advanced Therapeutics CrossRef - The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic cancer
Meng-Dan Xu et al, 2018, Oncogenesis CrossRef - Bioenergetic alteration in gastrointestinal cancers: The good, the bad and the ugly
Yu-De Chu et al, 2023, World Journal of Gastroenterology CrossRef - Anticancer Attributes of Cantharidin: Involved Molecular Mechanisms and Pathways
Faiza Naz et al, 2020, Molecules CrossRef